Medicare Enrolled

Dr. David Posner, M.D.

Pulmonary Disease · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
178 E 85TH ST, New York, NY 10028
2128618976
In practice since 2006 (19 years)
NPI: 1982794848 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Posner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Posner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Posner

Dr. David Posner is a pulmonary disease specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Posner performed 1,452 Medicare services across 1,161 unique beneficiaries.

Between the years covered by Open Payments, Dr. Posner received a total of $12,257 from 29 pharmaceutical and/or device companies across 612 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Posner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 28% volume in NY $12,257 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,452
Medicare services
Top 28% in NY for pulmonary disease
1,161
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~76 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
295 $105 $689
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
284 $24 $186
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
232 $80 $494
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
206 $30 $166
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
76 $53 $288
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
75 $36 $319
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
75 $40 $223
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
63 $156 $979
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
46 $101 $622
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
45 $151 $917
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $49 $313
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
18 $18 $108
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,257
Total received (2018-2024)
Avg $1,751/year across 7 years
Top 16% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
612
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,235 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,529
2023
$2,111
2022
$1,962
2021
$1,616
2020
$1,364
2019
$1,718
2018
$956

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$668
AstraZeneca Pharmaceuticals LP
$509
GENZYME CORPORATION
$256
Regeneron Healthcare Solutions, Inc.
$238
Mallinckrodt Hospital Products Inc.
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
Insmed, Inc.
$156
Baxter Healthcare
$100
Amgen Inc.
$74
Novartis Pharmaceuticals Corporation
$61
Mylan Specialty L.P.
$56
Electromed, Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$27
Paratek Pharmaceuticals, Inc.
$19
Top 3 companies account for 56.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,911
GlaxoSmithKline, LLC.
$2,527
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,588
Regeneron Healthcare Solutions, Inc.
$745
Insmed, Inc.
$711
GENZYME CORPORATION
$654
Mylan Specialty L.P.
$643
Amgen Inc.
$378
Mallinckrodt Hospital Products Inc.
$366
Genentech USA, Inc.
$325
Sunovion Pharmaceuticals Inc.
$284
Teva Pharmaceuticals USA, Inc.
$193
Novartis Pharmaceuticals Corporation
$172
Electromed, Inc.
$140
Baxter Healthcare
$100
Advanced Respiratory, Inc
$93
Merck Sharp & Dohme Corporation
$69
AbbVie, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$47
Philips Electronics North America Corporation
$43
Paratek Pharmaceuticals, Inc.
$39
Amarin Pharma Inc.
$35
Shire North American Group Inc
$33
United Therapeutics Corporation
$27
Merck Sharp & Dohme LLC
$22
Eisai Inc.
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
PFIZER INC.
$12
Circassia Pharmaceuticals Inc
$12
Top 3 companies account for 57.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · DUPIXENT · Dayvigo · Dymista · Esbriet · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · JANUVIA · JARDIANCE · LONHALA MAGNAIR · Life 2000 Ventilation System · NATPARA · NUCALA · NUZYRA · OFEV · PREVNAR - 13 · Perforomist · QVAR · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Synthroid · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Utibron · VERQUVO · Vascepa · XIFAXAN · XOLAIR · Xofluza · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in New York?
Compare pulmonary diseases in the New York area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
664
Per 100K population
40.8
County median income
$104,553
Nearest hospital
LENOX HILL HOSPITAL
0.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Posner is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NY), with low-engagement industry engagement in the top 16% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Posner experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Posner performed 295 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Posner receive payments from pharmaceutical companies?
Yes. Dr. Posner received a total of $12,257 from 29 companies across 612 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Posner's costs compare to other pulmonary diseases in New York?
Dr. Posner's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Posner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →